Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 12 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BIONOMICS LTD/ADR | 93,369,060 | reported | 04 Oct 2024 | tx 3−272,070 |
| AParadise Acquisition Corp. | 29,692,247 | reported | 07 May 2026 | tx 3+288,742,679 |
| Sensei Biotherapeutics, Inc. | 2,485,923 | reported | 23 Feb 2023 | tx 2+2,200 |
| ATAI Life Sciences N.V. | 0 | reported | 30 Sept 2025 | tx 12+24,051,327−147,950 |
| Alto Neuroscience, Inc. | 0 | reported | 06 Feb 2024 | tx 6+926,539−2,331,216 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 May 2026 | GRANT_AWARD | AParadise Acquisition Corp. | 29,692,247 | — | |
| 07 May 2026 | GRANT_AWARD | AParadise Acquisition Corp. | 258,837,933 | — | |
| 07 May 2026 | GRANT_AWARD | AParadise Acquisition Corp. | 212,499 | — | deriv |
| 30 Sept 2025 | CONVERSION | ATAI Life Sciences N.V. | 2,367,200 | — | |
| 30 Sept 2025 | CONVERSION | ATAI Life Sciences N.V. | 147,950 | — | deriv |
| 14 Aug 2025 | PURCHASE | ATAI Life Sciences N.V. | 8,675,799 | 2.19 USD | |
| 24 Mar 2025 | PURCHASE | ATAI Life Sciences N.V. | 1,800,000 | 1.40 USD | |
| 14 Feb 2025 | PURCHASE | ATAI Life Sciences N.V. | 10,835,718 | 2.10 USD | first after silence |
| 02 Oct 2024 | SALE | BIONOMICS LTD/ADR | 90,806 | 0.33 USD | |
| 03 Oct 2024 | SALE | BIONOMICS LTD/ADR | 180,707 | 0.29 USD | |
| 04 Oct 2024 | SALE | BIONOMICS LTD/ADR | 557 | 0.28 USD | |
| 06 Feb 2024 | CONVERSION | Alto Neuroscience, Inc. | 674,658 | — | |
| 06 Feb 2024 | CONVERSION | Alto Neuroscience, Inc. | 251,881 | — | |
| 06 Feb 2024 | CONVERSION | Alto Neuroscience, Inc. | 406,072 | — | deriv |
| 06 Feb 2024 | CONVERSION | Alto Neuroscience, Inc. | 416,665 | — | deriv |
| 06 Feb 2024 | CONVERSION | Alto Neuroscience, Inc. | 444,561 | — | deriv |
| 06 Feb 2024 | CONVERSION | Alto Neuroscience, Inc. | 1,063,918 | — | deriv |
| 23 Feb 2023 | PURCHASE | Sensei Biotherapeutics, Inc. | 1,100 | 1.62 USD | |
| 23 Feb 2023 | PURCHASE | Sensei Biotherapeutics, Inc. | 1,100 | 1.60 USD | |
| 20 Apr 2022 | PURCHASE | ATAI Life Sciences N.V. | 67,703 | 5.09 USD | |
| 21 Apr 2022 | PURCHASE | ATAI Life Sciences N.V. | 68,688 | 4.95 USD | |
| 19 Apr 2022 | PURCHASE | ATAI Life Sciences N.V. | 65,315 | 5.13 USD | |
| 18 Apr 2022 | PURCHASE | ATAI Life Sciences N.V. | 54,322 | 5.11 USD | |
| 14 Apr 2022 | PURCHASE | ATAI Life Sciences N.V. | 4,967 | 5.19 USD | |
| 11 Apr 2022 | PURCHASE | ATAI Life Sciences N.V. | 53,926 | 4.83 USD |
1 purchase reported after at least 12 months of silence — most recent on 14 Feb 2025.